Regulatory functions of miR‑200b‑3p in tumor development (Review)
- Authors:
- Sheng Chen
- Yifeng Tu
- Hang Yuan
- Zhan Shi
- Yang Guo
- Wenjing Gong
- Shiliang Tu
-
Affiliations: General Surgery, Cancer Center, Department of Colorectal Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang 310014, P.R. China, The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310014, P.R. China - Published online on: March 23, 2022 https://doi.org/10.3892/or.2022.8307
- Article Number: 96
-
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI | |
Kozomara A, Birgaoanu M and Griffiths-Jones S: miRBase: From microRNA sequences to function. Nucleic Acids Res. 47(D1): D155–D162. 2019. View Article : Google Scholar : PubMed/NCBI | |
Ha M and Kim VN: Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI | |
Chen L, Wang X, Zhu Y, Zhu J and Lai Q: miR-200b-3p inhibits proliferation and induces apoptosis in colorectal cancer by targeting Wnt1. Mol Med Rep. 18:2571–2580. 2018.PubMed/NCBI | |
Feifei W, Hui G, Ruiqiang Z, Qunxiang J and Yu'an X: MAGP2, a component of extracellular matrix, is upregulated in colorectal cancer and negatively modulated by miR-200b-3p. Technol Cancer Res Treat. 18:15330338198707772019. View Article : Google Scholar : PubMed/NCBI | |
Lv Z, Wei J, You W, Wang R, Shang J, Xiong Y, Yang H, Yang X and Fu Z: Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer. J Transl Med. 15:2572017. View Article : Google Scholar : PubMed/NCBI | |
Chen DL, Chen LZ, Lu YX, Zhang DS, Zeng ZL, Pan ZZ, Huang P, Wang FH, Li YH, Ju HQ and Xu RH: Long noncoding RNA XIST expedites metastasis and modulates epithelial-mesenchymal transition in colorectal cancer. Cell Death Dis. 8:e30112017. View Article : Google Scholar : PubMed/NCBI | |
Moh-Moh-Aung A, Fujisawa M, Ito S, Katayama H, Ohara T, Ota Y, Yoshimura T and Matsukawa A: Decreased miR-200b-3p in cancer cells leads to angiogenesis in HCC by enhancing endothelial ERG expression. Sci Rep. 10:104182020. View Article : Google Scholar : PubMed/NCBI | |
Qiu W, Wang Z, Chen R, Shi H, Ma Y and Zhou H, Li M, Li W, Chen H and Zhou H: Xiaoai jiedu recipe suppresses hepatocellular carcinogenesis through the miR-200b-3p/Notch1 axis. Cancer Manag Res. 12:11121–11131. 2020. View Article : Google Scholar : PubMed/NCBI | |
Liu L, Jiang H, Pan H and Zhu X: LncRNA XIST promotes liver cancer progression by acting as a molecular sponge of miR-200b-3p to regulate ZEB1/2 expression. J Int Med Res. 49:30006052110162112021.PubMed/NCBI | |
Liu WG and Xu Q: Long non-coding RNA XIST promotes hepatocellular carcinoma progression by sponging miR-200b-3p. Eur Rev Med Pharmacol Sci. 23:9857–9862. 2019.PubMed/NCBI | |
Huang Z, Chu L, Liang J, Tan X, Wang Y, Wen J, Chen J, Wu Y, Liu S, Liao J, et al: H19 promotes HCC bone metastasis through reducing osteoprotegerin expression in a protein phosphatase 1 catalytic subunit alpha/p38 mitogen-activated protein kinase-dependent manner and sponging microRNA 200b-3p. Hepatology. 74:214–232. 2021. View Article : Google Scholar : PubMed/NCBI | |
Nwaeburu CC, Abukiwan A, Zhao Z and Herr I: Quercetin-induced miR-200b-3p regulates the mode of self-renewing divisions in pancreatic cancer. Mol Cancer. 16:232017. View Article : Google Scholar : PubMed/NCBI | |
Gui Z, Luo F, Yang Y, Shen C, Li S and Xu J: Oridonin inhibition and miR-200b-3p/ZEB1 axis in human pancreatic cancer. Int J Oncol. 50:111–120. 2017. View Article : Google Scholar : PubMed/NCBI | |
Gyvyte U, Lukosevicius R, Inciuraite R, Streleckiene G, Gudoityte G, Bekampyte J, Valentini S, Salteniene V, Ruzgys P, Satkauskas S, et al: The role of miR-375-3p and miR-200b-3p in gastrointestinal stromal tumors. Int J Mol Sci. 21:51512020. View Article : Google Scholar : PubMed/NCBI | |
Li D, Wang H, Song H, Xu H, Zhao B, Wu C, Hu J, Wu T, Xie D, Zhao J, et al: The microRNAs miR-200b-3p and miR-429-5p target the LIMK1/CFL1 pathway to inhibit growth and motility of breast cancer cells. Oncotarget. 8:85276–85289. 2017. View Article : Google Scholar : PubMed/NCBI | |
Zhang X, Wang M, Sun H, Zhu T and Wang X: Downregulation of LINC00894-002 contributes to tamoxifen resistance by enhancing the TGF-β signaling pathway. Biochemistry (Mosc). 83:603–611. 2018. View Article : Google Scholar : PubMed/NCBI | |
Rhodes LV, Martin EC, Segar HC, Miller DF, Buechlein A, Rusch DB, Nephew KP, Burow ME and Collins-Burow BM: Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer. Oncotarget. 6:16638–16652. 2015. View Article : Google Scholar : PubMed/NCBI | |
Zhou WJ, Wang HY, Zhang J, Dai HY, Yao ZX, Zheng Z, Meng-Yan S and Wu K: NEAT1/miR-200b-3p/SMAD2 axis promotes progression of melanoma. Aging (Albany NY). 12:22759–22775. 2020.PubMed/NCBI | |
Liu J, Wang L and Li X: HMGB3 promotes the proliferation and metastasis of glioblastoma and is negatively regulated by miR-200b-3p and miR-200c-3p. Cell Biochem Funct. 36:357–365. 2018. View Article : Google Scholar : PubMed/NCBI | |
Wu J, Cui H, Zhu Z and Wang L: MicroRNA-200b-3p suppresses epithelial-mesenchymal transition and inhibits tumor growth of glioma through down-regulation of ERK5. Biochem Biophys Res Commun. 478:1158–1164. 2016. View Article : Google Scholar : PubMed/NCBI | |
Xu B, Qin T, Yu J, Giordano TJ, Sartor MA and Koenig RJ: Novel role of ASH1L histone methyltransferase in anaplastic thyroid carcinoma. J Biol Chem. 295:8834–8845. 2020. View Article : Google Scholar : PubMed/NCBI | |
Pereira TDSF, Brito JAR, Guimarães ALS, Gomes CC, de Lacerda JCT, de Castro WH, Coimbra RS, Diniz MG and Gomez RS: MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma. J Oral Pathol Med. 47:78–85. 2018. View Article : Google Scholar : PubMed/NCBI | |
Ma J, Xiao Y, Tian B, Chen S, Zhang B, Wu J, Wu Z, Li X, Tang J, Yang D, et al: Long noncoding RNA lnc-ABCA12-3 promotes cell migration, invasion, and proliferation by regulating fibronectin 1 in esophageal squamous cell carcinoma. J Cell Biochem. 121:1374–1387. 2020. View Article : Google Scholar : PubMed/NCBI | |
Pan J and Zang Y: LINC00667 promotes progression of esophageal cancer cells by regulating miR-200b-3p/SLC2A3 axis. Dig Dis Sci. Jul 27–2021.(Epub ahead of print). doi: 10.1007/s10620-021-07145-5. View Article : Google Scholar | |
Masaoka T, Shinozuka K, Ohara K, Tsuda H, Imai K and Tonogi M: Bioinformatics analysis of dysregulated exosomal microRNAs derived from oral squamous cell carcinoma cells. J Oral Sci. 63:174–178. 2021. View Article : Google Scholar : PubMed/NCBI | |
Li F, Lu T, Liu D, Zhang C, Zhang Y and Dong F: Upregulated PPARG2 facilitates interaction with demethylated AKAP12 gene promoter and suppresses proliferation in prostate cancer. Cell Death Dis. 12:5282021. View Article : Google Scholar : PubMed/NCBI | |
He M, Liu Y, Deng X, Qi S, Sun X, Liu G, Liu Y, Liu Y and Zhao M: Down-regulation of miR-200b-3p by low p73 contributes to the androgen-independence of prostate cancer cells. Prostate. 73:1048–1056. 2013. View Article : Google Scholar : PubMed/NCBI | |
Dong Y, Zhai W and Xu Y: Bioinformatic gene analysis for potential biomarkers and therapeutic targets of diabetic nephropathy associated renal cell carcinoma. Transl Androl Urol. 9:2555–2571. 2020. View Article : Google Scholar : PubMed/NCBI | |
Ma X, Ying Y, Sun J, Xie H, Li J, He L, Wang W, Chen S, Shen H, Yi J, et al: circKDM4C enhances bladder cancer invasion and metastasis through miR-200bc-3p/ZEB1 axis. Cell Death Discov. 7:3652021. View Article : Google Scholar : PubMed/NCBI | |
Micolucci L, Akhtar MM, Olivieri F, Rippo MR and Procopio AD: Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: Systematic review and qualitative meta-analysis. Oncotarget. 7:58606–58637. 2016. View Article : Google Scholar : PubMed/NCBI | |
Pełka K, Klicka K, Grzywa TM, Gondek A, Marczewska JM, Garbicz F, Szczepaniak K, Paskal W and Włodarski PK: miR-96-5p, miR-134-5p, miR-181b-5p and miR-200b-3p heterogenous expression in sites of prostate cancer versus benign prostate hyperplasia-archival samples study. Histochem Cell Biol. 155:423–433. 2021. View Article : Google Scholar : PubMed/NCBI | |
Janiak M, Paskal W, Rak B, Garbicz F, Jarema R, Sikora K and Włodarski P: TIMP4 expression is regulated by miR-200b-3p in prostate cancer cells. APMIS. 125:101–105. 2017. View Article : Google Scholar : PubMed/NCBI | |
Liu K, Zhang W, Tan J, Ma J and Zhao J: MiR-200b-3p functions as an oncogene by targeting ABCA1 in lung adenocarcinoma. Technol Cancer Res Treat. 18:15330338198925902019. View Article : Google Scholar : PubMed/NCBI | |
Wang L, Tong X, Zhou Z, Wang S, Lei Z, Zhang T, Liu Z, Zeng Y, Li C, Zhao J, et al: Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer. Mol Cancer. 17:1402018. View Article : Google Scholar : PubMed/NCBI | |
Chi Y, Zheng W, Bao G, Wu L, He X, Gan R, Shen Y, Yin X and Jin M: Circular RNA circ_103820 suppresses lung cancer tumorigenesis by sponging miR-200b-3p to release LATS2 and SOCS6. Cell Death Dis. 12:1852021. View Article : Google Scholar : PubMed/NCBI | |
Wang Y, Xu YM, Zou YQ, Lin J, Huang B, Liu J, Li J, Zhang J, Yang WM, Min QH, et al: Identification of differential expressed PE exosomal miRNA in lung adenocarcinoma, tuberculosis, and other benign lesions. Medicine (Baltimore). 96:e83612017. View Article : Google Scholar : PubMed/NCBI | |
Xie K, Wang C, Qin N, Yang J, Zhu M, Dai J, Jin G, Shen H, Ma H and Hu Z: Genetic variants in regulatory regions of microRNAs are associated with lung cancer risk. Oncotarget. 7:47966–47974. 2016. View Article : Google Scholar : PubMed/NCBI | |
Sun G, Cao Y, Wang P, Song H, Bie T, Li M and Huai D: miR-200b-3p in plasma is a potential diagnostic biomarker in oral squamous cell carcinoma. Biomarkers. 23:137–141. 2018. View Article : Google Scholar : PubMed/NCBI | |
Ishibashi O, Akagi I, Ogawa Y and Inui T: MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway. Biochem Biophys Res Commun. 501:507–513. 2018. View Article : Google Scholar : PubMed/NCBI | |
Amorim M, Lobo J, Fontes-Sousa M, Estevão-Pereira H, Salta S, Lopes P, Coimbra N, Antunes L, Palma de Sousa S, Henrique R and Jerónimo C: Predictive and prognostic value of selected MicroRNAs in luminal breast cancer. Front Genet. 10:8152019. View Article : Google Scholar : PubMed/NCBI | |
Guo L, Yang G, Kang Y, Li S, Duan R, Shen L, Jiang W, Qian B, Yin Z and Liang T: Construction and analysis of a ceRNA network reveals potential prognostic markers in colorectal cancer. Front Genet. 11:4182020. View Article : Google Scholar : PubMed/NCBI | |
Della Vittoria Scarpati G, Calura E, Di Marino M, Romualdi C, Beltrame L, Malapelle U, Troncone G, De Stefano A, Pepe S, De Placido S, et al: Analysis of differential miRNA expression in primary tumor and stroma of colorectal cancer patients. Biomed Res Int. 2014:8409212014. View Article : Google Scholar : PubMed/NCBI | |
Patil S and Warnakulasuriya S: Blood-based circulating microRNAs as potential biomarkers for predicting the prognosis of head and neck cancer-a systematic review. Clin Oral Investig. 24:3833–3841. 2020. View Article : Google Scholar : PubMed/NCBI | |
Shen L, Chen G, Xia Q, Shao S and Fang H: Exosomal miR-200 family as serum biomarkers for early detection and prognostic prediction of cholangiocarcinoma. Int J Clin Exp Pathol. 12:3870–3876. 2019.PubMed/NCBI | |
Livingstone MC, Johnson NM, Roebuck BD, Kensler TW and Groopman JD: Profound changes in miRNA expression during cancer initiation by aflatoxin B1 and their abrogation by the chemopreventive triterpenoid CDDO-Im. Mol Carcinog. 56:2382–2390. 2017. View Article : Google Scholar : PubMed/NCBI | |
Usman S, Waseem NH, Nguyen TKN, Mohsin S, Jamal A, Teh MT and Waseem A: Vimentin is at the heart of epithelial mesenchymal transition (EMT) mediated metastasis. Cancers (Basel). 13:49852021. View Article : Google Scholar : PubMed/NCBI | |
Zhang P, Sun Y and Ma L: ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance. Cell Cycle. 14:481–487. 2015. View Article : Google Scholar : PubMed/NCBI | |
Qin Y, Yu J, Zhang M, Qin F and Lan X: ZEB1 promotes tumorigenesis and metastasis in hepatocellular carcinoma by regulating the expression of vimentin. Mol Med Rep. 19:2297–2306. 2019.PubMed/NCBI | |
Liu J, Cao L, Meng J, Li Y, Deng P, Pan P, Hu C and Yang H: The fibrotic microenvironment promotes the metastatic seeding of tumor cells into the lungs via mediating the ZEB1-AS1/miR-200b-3p/ ZEB1 signaling. Cell Cycle. 19:2701–2719. 2020. View Article : Google Scholar : PubMed/NCBI | |
Wu YZ, Lin HY, Zhang Y and Chen WF: miR-200b-3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer. J Gene Med. 22:e31782020. View Article : Google Scholar : PubMed/NCBI | |
Kolacinska A, Morawiec J, Fendler W, Malachowska B, Morawiec Z, Szemraj J, Pawlowska Z, Chowdhury D, Choi YE, Kubiak R, et al: Association of microRNAs and pathologic response to preoperative chemotherapy in triple negative breast cancer: Preliminary report. Mol Biol Rep. 41:2851–2857. 2014. View Article : Google Scholar : PubMed/NCBI | |
Xia L, Han Q, Chi C, Zhu Y, Pan J, Dong B, Huang Y, Xia W, Xue W and Sha J: Transcriptional regulation of PRKAR2B by miR-200b-3p/200c-3p and XBP1 in human prostate cancer. Biomed Pharmacother. 124:1098632020. View Article : Google Scholar : PubMed/NCBI | |
Samli H, Samli M, Vatansever B, Ardicli S, Aztopal N, Dincel D, Sahin A and Balci F: Paclitaxel resistance and the role of miRNAs in prostate cancer cell lines. World J Urol. 37:1117–1126. 2019. View Article : Google Scholar : PubMed/NCBI | |
Doğanlar O, Doğanlar ZB, Delen E and Doğan A: The role of melatonin in angio-miR-associated inhibition of tumorigenesis and invasion in human glioblastoma tumour spheroids. Tissue Cell. 73:1016172021. View Article : Google Scholar : PubMed/NCBI | |
Zhu KP, Zhang CL, Ma XL, Hu JP, Cai T and Zhang L: Analyzing the interactions of mRNAs and ncRNAs to predict competing endogenous RNA networks in osteosarcoma chemo-resistance. Mol Ther. 27:518–530. 2019. View Article : Google Scholar : PubMed/NCBI | |
Kun-Peng Z, Chun-Lin Z, Xiao-Long M and Lei Z: Fibronectin-1 modulated by the long noncoding RNA OIP5-AS1/miR-200b-3p axis contributes to doxorubicin resistance of osteosarcoma cells. J Cell Physiol. 234:6927–6939. 2019. View Article : Google Scholar : PubMed/NCBI | |
Jones M and Lal A: MicroRNAs, wild-type and mutant p53: More questions than answers. RNA Biol. 9:781–791. 2012. View Article : Google Scholar : PubMed/NCBI | |
Briand J, Sérandour AA, Nadaradjane A, Bougras-Cartron G, Heymann D, Ory B, Vallette FM and Cartron PF: N6-adenosine methylation of miRNA-200b-3p influences its functionality and is a theranostic tool. Mol Ther Nucleic Acids. 22:72–83. 2020.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI | |
Davalos V, Moutinho C, Villanueva A, Boque R, Silva P, Carneiro F and Esteller M: Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. Oncogene. 31:2062–2074. 2012. View Article : Google Scholar : PubMed/NCBI |